Transcatheter Valve Replacement Market to Reach $12.5 Billion by 2035, Growing at 9.1% CAGR

The transcatheter valve replacement market will be USD 5,246 million in 2025; according to Fact MR's analysis, the industry will expand at a CAGR of 9.1% and reach USD 12,524 million by 2035. The key driver is the increasing incidence of valvular heart disease among the geriatric population, combined with the minimally invasive procedure being less risky and with shorter recovery time compared to traditional open-heart surgeries.

The transcatheter valve replacement market has emerged rapidly as a disruptive force in cardiovascular procedures, particularly among high-risk or inoperable patients. Expanded clinical acceptance, together with advances in the procedure, has spread its application to aortic, mitral, and pulmonary valve replacement. To further gain a share in advanced economies, senior executives are investing in new delivery mechanisms and the next wave of valves, which will offer better hemodynamic outcomes and resilience.

For More Insights into the Market, Request a Sample of this Report:https://www.factmr.com/connectus/sample?flag=S&rep_id=7388

Key Market Drivers

Minimally Invasive Procedures: TVR procedures are less invasive compared to traditional surgeries, leading to shorter hospital stays and quicker recovery times. This is particularly beneficial for high-risk patients who may not be suitable candidates for open-heart surgery
Aging Population: The global increase in the elderly population has led to a higher prevalence of valvular heart diseases, such as aortic stenosis, thereby increasing the demand for TVR procedures .​
Technological Advancements: Innovations in imaging technologies, catheter designs, and valve materials have improved the safety and efficacy of TVR procedures, making them more accessible and appealing to both patients and healthcare providers .​

Market Segmentation

By Replacement Type:
Transcatheter Aortic Valve Replacement (TAVR): Dominates the market with a 78.6% share as of 2021, due to its applicability across various risk categories and less invasive nature .
Transcatheter Mitral Valve Repair (TMVR): Accounts for 21.4% of the market, with ongoing research and development expected to boost its adoption in the coming years
By Surgical Approach:
Trans-femoral Approach: Holds a significant market share of 78.9%, favored for its less invasive technique and reduced recovery time .
Trans-apical and Trans-aortic Approaches: Used in specific cases where the trans-femoral approach is not feasible.​
By End User:
Hospitals: Represent the largest end-user segment, accounting for 65.4% of the market, due to the availability of advanced medical infrastructure and skilled healthcare professionals .
Ambulatory Surgical Centers and Specialty Clinics: Also contribute to the market, offering specialized care and convenience for patients

Regional Insights

North America: Leads the global TVR market with a 27% share, driven by a high prevalence of heart valve diseases, favorable reimbursement policies, and advanced healthcare infrastructure .
Europe: Germany dominates the European market with a 23.4% share, attributed to improved healthcare infrastructure and a growing geriatric population .​
Asia-Pacific: Expected to witness significant growth due to a large patient pool, increasing healthcare expenditures, and rising awareness about minimally invasive procedures .​

Competitive Landscape

Key players in the TVR market include Edwards Lifesciences Corporation, Medtronic Inc., Boston Scientific Corporation, and Abbott Laboratories. These companies are focusing on strategic collaborations, product innovations, and expanding their geographical presence to strengthen their market position.​

In September 2022, Edwards Lifesciences launched the Sapien 3 Ultra Resilia Valve, the first dry-storage transcatheter heart valve in the U.S., enhancing procedural efficiency .​
Medtronic received approval for its Evolut PRO TAVR System in China in January 2022, expanding its footprint in the Asia-Pacific region

Get Customization on this Report for Specific Research Solutions:https://www.factmr.com/connectus/sample?flag=S&rep_id=7388

Challenges and Opportunities

While the TVR market shows promising growth, challenges such as potential procedural risks (e.g., bleeding, infection, stroke), high costs, and the need for specialized training for healthcare providers may hinder market expansion. However, ongoing research and development, along with technological advancements, present opportunities for market growth and improved patient outcomes.​

Conclusion

The transcatheter valve replacement market is poised for substantial growth, driven by the increasing demand for minimally invasive procedures, technological advancements, and a growing aging population. With continued innovation and strategic initiatives by key market players, the TVR market is expected to offer improved treatment options for patients with valvular heart diseases worldwide.​

Explore More Related Studies Published by Fact.MR Research:

Veterinary Molecular Diagnostics Market

https://www.factmr.com/report/veterinary-molecular-diagnostics-market

Uterine Cancer Diagnostic Testing Market

https://www.factmr.com/report/uterine-cancer-diagnostic-testing-market

Cell-Free Protein Expression Market

https://www.factmr.com/report/cell-free-protein-expression-market

Pseudarthrosis Treatment Market

https://www.factmr.com/report/pseudarthrosis-treatment-market

Pertussis Treatment Market

https://www.factmr.com/report/pertussis-treatment-market

.

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

About Fact.MR:

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction

This release was published on openPR.